ClinicalTrials.Veeva

Menu

Psoriasis and the Risk of Cardiovascular Disease. A Prospective Study

University of Oslo (UIO) logo

University of Oslo (UIO)

Status

Unknown

Conditions

Psoriasis
Cardiovascular Disease

Study type

Observational

Funder types

Other

Identifiers

NCT01382784
Psoriasis and comorbidity

Details and patient eligibility

About

There is growing evidence that psoriasis is a systemic disorder which enhances atherosclerosis and the risk of cardiovascular disease. Epidemiological studies have shown an independent association between psoriasis and atherosclerosis, stroke and coronary artery disease. The main goal of this on-going study is to register data which will enable the identification of new markers of atherosclerosis activity and carotid plaque instability in patients with severe psoriasis.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • >18 years old, psoriasis for more than 5 years, moderate to severe psoriasis (PASI >10 or systemic treatment)

Exclusion criteria

  • familiar hypercholesterolemia, ongoing infections and cancer disease

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems